Yousif Capital Management’s Ginkgo Bioworks DNA Stock Holding History

Yousif Capital Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-405	Closed	-$18.8K	–	1971
2024 Q1	$18.8K	Buy	405 +41	+11%	+$2.12K	﹤0.01%	1976
2023 Q4	$24.6K	Buy	364 +23	+7%	+$1.41K	﹤0.01%	1978
2023 Q3	$24.7K	Hold	341	–	–	﹤0.01%	1969
2023 Q2	$25.4K	Buy	+341	New	+$20.2K	﹤0.01%	1955

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Yousif Capital Management's DNA Position: Q2 2024 in Review

Yousif Capital Management sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 405 shares — an estimated $18.8K sold.

Yousif Capital Management first reported a position in DNA in Q2 2023 and held it in 4 quarters. The position peaked at $25.4K in Q2 2023. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

Yousif Capital Management reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
Yousif Capital Management sold 405 Ginkgo Bioworks shares in Q2 2024, an estimated $18.8K.
Yousif Capital Management first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 4 quarters.
Yousif Capital Management's Ginkgo Bioworks position peaked at $25.4K in Q2 2023.
313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Yousif Capital Management's 13F filing for Q2 2024, filed 31 Jul 2024.